IFP Advisors’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Sell
11,871
-131
-1% -$5.1K 0.01% 1043
2026
Q1
$422K Buy
12,002
+38
+0.3% +$1.44K 0.01% 1038
2025
Q4
$461K Hold
11,964
0.01% 973
2025
Q3
$449K Buy
11,964
+295
+3% +$10.2K 0.01% 897
2025
Q2
$380K Buy
11,669
+968
+9% +$27.6K 0.01% 947
2025
Q1
$323K Buy
10,701
+566
+6% +$20.1K 0.01% 953
2024
Q4
$366K Buy
10,135
+864
+9% +$31.8K 0.01% 868
2024
Q3
$327K Sell
9,271
-19,982
-68% -$668K 0.01% 862
2024
Q2
$996K Sell
29,253
-6,353
-18% -$197K 0.04% 441
2024
Q1
$1.1M Buy
35,606
+20,309
+133% +$585K 0.05% 391
2023
Q4
$407K Sell
15,297
-42,794
-74% -$1.05M 0.02% 646
2023
Q3
$1.38M Sell
58,091
-2,428
-4% -$62.5K 0.06% 310
2023
Q2
$1.57M Buy
+60,519
New +$1.53M 0.07% 307

Other funds holding HCMT

IFP Advisors's HCMT Position: Q2 2026 in Review

IFP Advisors reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 1.1% in Q2 2026, selling an estimated $5.1K and leaving 11,871 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #1043.

IFP Advisors first reported a position in HCMT in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.57M in Q2 2023. 41 funds tracked by Wall St. Rank hold HCMT as of Q2 2026.

  • IFP Advisors held 11,871 shares of Direxion HCM Tactical Enhanced US ETF worth $498K as of Q2 2026.
  • IFP Advisors sold 131 Direxion HCM Tactical Enhanced US ETF shares in Q2 2026, an estimated $5.1K.
  • Direxion HCM Tactical Enhanced US ETF made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1043 holding.
  • IFP Advisors first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2023 and has held it in 13 quarters since.
  • IFP Advisors's Direxion HCM Tactical Enhanced US ETF position peaked at $1.57M in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.